Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

NCT07562763 is registered in ClinicalTrials.gov with Anhui Provincial Hospital as lead sponsor.

NCT NCT07562763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07562763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma
Lead sponsor
Anhui Provincial Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
December 31, 2025
Enrollment
1,005 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant therapy, hepatocellular carcinoma (hcc), machine learning, transarterial chemoembolization, treatment effectiveness